How did BHST's revenue and expenses trend in Q4 2024?

In Q4 2024, BioHarvest Sciences (BHST) reported a revenue of $282,000, with operating expenses amounting to $2.96 million, resulting in a net loss. The gross profit margin stood at 55.35% for the period. |code|Ticker|Name|Date|Business Composition|Revenue By Business|market_code| |---|---|---|---|---|---|---| |BHST|BHST.O|BioHarvest Sciences|20240101-2024|Contract Development And Manufacturing Operation Services|282000|185| |BHST|BHST.O|BioHarvest Sciences|20240101-2024|Contract Development And Manufacturing Operation Services|232000|185| |BHST|BHST.O|BioHarvest Sciences|20240101-2024|Contract Development And Manufacturing Operation Services|75000|185| |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |BHST|BHST.O|BioHarvest Sciences|2024 Q1|-775.1329787234042|-6581000|185| |BHST|BHST.O|BioHarvest Sciences|2024 Q3|-55.70353213665315|-2689000|185| |BHST|BHST.O|BioHarvest Sciences|2024 Q4|59.14305459571527|-2956000|185| |code|Ticker|Name|Date|Gross Profit Margin|Gross Profit Margin YoY|market_code| |---|---|---|---|---|---|---| |BHST|BHST.O|BioHarvest Sciences|2024 Q1|56.1939|53.46899425930882|185| |BHST|BHST.O|BioHarvest Sciences|2024 Q3|54.8241||185| |BHST|BHST.O|BioHarvest Sciences|2024 Q4|55.3518|24.519541171098|185|